01/13/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/01/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
12/31/2024
3:15 PM | Aclaris Therapeutics (Filer)
| Form 424B3 | |
12/19/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/12/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
7:06 AM | Aclaris Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
|
12/03/2024
4:42 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:02 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/25/2024
10:02 AM | Aclaris Therapeutics (Subject)
Biosion, Inc. (Filed by)
| Form SC 13G | |
11/25/2024
10:03 AM | Aclaris Therapeutics (Issuer)
Biosion, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Aclaris Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
11/20/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2024
7:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:21 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:18 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:10 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Aclaris Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
07/05/2024
1:46 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
12:39 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:04 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Crypto Is Set to Explode in January (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/25/2024
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:02 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
04/03/2024
4:00 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
6:14 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:32 PM | Aclaris Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
9:30 AM | Aclaris Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
1:24 PM | Aclaris Therapeutics (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
10:14 AM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
9:47 AM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:29 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:31 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:36 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:27 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form 8-K/A | |
